贫血与心血管并发症：铁和促红细胞生成素的影响
Anemia and cardiovascular complications: iron and EPO impact.
作者信息
Kurtzman N A, Sabatini S
机构信息
Texas Tech University Health Sciences Center, Department of Internal Medicine and Physiology and Combined Program in Nephrology and Renal Physiology, Lubbock, Tex. 79430, USA.
出版信息
Miner Electrolyte Metab. 1999 Jan-Apr;25(1-2):109-13. doi: 10.1159/000057431.
PMID:10207271
Abstract
Management of end-stage renal disease (ESRD) has been revolutionized by the advent of erythropoietin replacement. We briefly review its characteristics and clinical use. Also emphasized is the importance of iron deficiency in limiting the clinical response to erythropoietin therapy. Iron-replacement therapy in ESRD patients is briefly discussed.
摘要
促红细胞生成素替代疗法的出现彻底改变了终末期肾病（ESRD）的治疗方式。我们简要回顾其特点及临床应用。同时强调缺铁在限制促红细胞生成素治疗临床反应方面的重要性。并简要讨论了ESRD患者的铁替代疗法。
Zotero 插件